Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Core Scientific (CORZW) Cash from Investing Activities (2021 - 2025)

Core Scientific (CORZW) has disclosed Cash from Investing Activities for 5 consecutive years, with -$277.8 million as the latest value for Q4 2025.

  • Quarterly Cash from Investing Activities fell 864.54% to -$277.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$740.8 million through Dec 2025, down 678.16% year-over-year, with the annual reading at -$740.8 million for FY2025, 678.16% down from the prior year.
  • Cash from Investing Activities hit -$277.8 million in Q4 2025 for Core Scientific, down from -$254.4 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $2.4 million in Q4 2023 to a low of -$308.3 million in Q4 2021.
  • Historically, Cash from Investing Activities has averaged -$92.7 million across 5 years, with a median of -$31.6 million in 2024.
  • Biggest five-year swings in Cash from Investing Activities: skyrocketed 101.69% in 2023 and later plummeted 3656.53% in 2025.
  • Year by year, Cash from Investing Activities stood at -$308.3 million in 2021, then skyrocketed by 54.76% to -$139.5 million in 2022, then surged by 101.69% to $2.4 million in 2023, then crashed by 1320.25% to -$28.8 million in 2024, then tumbled by 864.54% to -$277.8 million in 2025.
  • Business Quant data shows Cash from Investing Activities for CORZW at -$277.8 million in Q4 2025, -$254.4 million in Q3 2025, and -$119.6 million in Q2 2025.